Full text is available at the source.
Endocrine···
Effectiveness and safety of GLP-1 receptor drugs for type 2 diabetes and obesity in people with Cushing's syndrome
Updated
Funding
Competing interests
Declarations. Conflict of interests: The authors declare no competing interests.
PubMed
Related papers
Mar '26
Comparing the effectiveness and safety of Tirzepatide, Liraglutide, and Semaglutide for treating obesity without diabetes
top 20% journal
cited by 1 paper
journal article
Jul '25
How Tirzepatide, Liraglutide, and Semaglutide Compare in Lowering Heart Event Risks for People with Sleep Apnea and Type 2 Diabetes
top 10% journal
cited by 12 papers
comparative study
Jul '25
Effectiveness and safety of GLP-1 drugs for treating type 2 diabetes
top 20% journal
cited by 18 papers
systematic review
Sep '25
Comparing GLP-1 and combined GLP-1/GIP treatments for lowering serious liver problems in type 2 diabetes
top 5% journal
cited by 6 papers
comparative study
Oct '25
Weight loss over 12 months in people with type 1 diabetes using tirzepatide, semaglutide, or liraglutide
top 5% journal
cited by 3 papers
comparative study
Sep '23
How 10 diabetes drugs added to metformin compare in effectiveness and safety for type 2 diabetes
top 10% journal
cited by 41 papers
systematic review
Dec '25
GLP-1 drugs and their link to thoughts of suicide: A combined analysis
top 50% journal
cited by 1 paper
meta-analysis
Oct '25
Comparing the effectiveness of GLP-1 and combined GLP-1/GIP receptor drugs in preventing alcohol use disorders
top 5% journal
cited by 2 papers
journal article
Apr '25
Effectiveness and Safety of GLP-1 Medicines for Weight Return or Poor Results After Metabolic Weight-Loss Surgery: A Meta-Analysis
top 20% journal
cited by 4 papers
systematic review